Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics

Cancer

Volumn 124, Issue 13, 2018, Pages 2785-2800

  Cronin, Kathleen A ^a   Lake, Andrew J ^b   Scott, Susan ^a   Sherman, Recinda L ^c   Noone, Anne Michelle ^a   Howlader, Nadia ^a   Henley, S Jane ^d   Anderson, Robert N ^e   Firth, Albert U ^b   Ma, Jiemin ^f   Kohler, Betsy A ^c   Jemal, Ahmedin ^f  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INFORMATION MANAGEMENT SERVICES INC   (United States)

^c North American Association of Central Cancer Registries   (United States)

^d NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^e NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

^f AMERICAN CANCER SOCIETY   (United States)

Author keywords

and End Results (SEER); Annual Report to the Nation; cancer; Epidemiology; incidence; mortality; National Program of Cancer Registries (NPCR); National Vital Statistics System (NVSS); North American Association of Central Cancer Registries (NAACCR); Surveillance; survival; trends

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN CANCER; BREAST CANCER; BRONCHUS CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; CANCER STATISTICS; CANCER SURVIVAL; CHILD; COLORECTAL CANCER; CUTANEOUS MELANOMA; ETHNICITY; FEMALE; HEALTH CARE MANAGEMENT; HEART CANCER; HUMAN; INFANT; LUNG CANCER; MALE; MALIGNANT NEOPLASM; MOUTH CANCER; NEWBORN; NON MELANOMA SKIN CANCER; PHARYNX CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RACE; SEX DIFFERENCE; SOFT TISSUE CANCER; UTERUS CANCER; CAUSE OF DEATH; INCIDENCE; NATIONAL HEALTH ORGANIZATION; NEOPLASM; NON PROFIT ORGANIZATION; PATHOLOGY; POPULATION RESEARCH; PREVENTIVE HEALTH SERVICE; SEX FACTOR; SURVIVAL ANALYSIS; UNITED STATES;

AMERICAN CANCER SOCIETY; CAUSE OF DEATH; CENSUSES; FEMALE; HUMANS; INCIDENCE; MALE; NATIONAL CANCER INSTITUTE (U.S.); NEOPLASM STAGING; NEOPLASMS; PREVENTIVE HEALTH SERVICES; SEER PROGRAM; SEX FACTORS; SURVIVAL ANALYSIS; UNITED STATES;

EID: 85047501556     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.31551     Document Type: Article

References (65)

1. Wingo PA, Ries LA, Rosenberg HM, Miller DS, Edwards BK. Cancer incidence and mortality, 1973-1995: a report card for the United States. Cancer. 1998;82:1197-1207.
2. Wingo PA, Ries LA, Giovino GA, et al. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst. 1999;91:675-690.
3. Ries LA, Wingo PA, Miller DS, et al. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer. 2000;88:2398-2424.
4. Howe HL, Wingo PA, Thun MJ, et al. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst. 2001;93:824-842.
5. Edwards BK, Howe HL, Ries LA, et al. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on US cancer burden. Cancer. 2002;94:2766-2792.
6. Weir HK, Thun MJ, Hankey BF, et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst. 2003;95:1276-1299.
7. Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer. 2004;101:3-27.
8. Edwards BK, Brown ML, Wingo PA, et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst. 2005;97:1407-1427.
9. Howe HL, Wu X, Ries LA, et al. Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among US Hispanic/Latino populations. Cancer. 2006;107:1711-1742.
10. Espey DK, Wu XC, Swan J, et al. Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer. 2007;110:2119-2152.
11. Jemal A, Thun MJ, Ries LA, et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst. 2008;100:1672-1694.
12. Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116:544-573.
13. Kohler BA, Ward E, McCarthy BJ, et al. Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst. 2011;103:714-736.
14. Eheman C, Henley SJ, Ballard-Barbash R, et al. Annual report to the nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer. 2012;118:2338-2366.
15. Jemal A, Simard EP, Dorell C, et al. Annual report to the nation on the status of cancer, 1975-2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst. 2013;105:175-201.
16. Edwards BK, Noone AM, Mariotto AB, et al. Annual report to the nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 2014;120:1290-1314.
17. Kohler BA, Sherman RL, Howlader N, et al. Annual report to the nation on the status of cancer, 1975-2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state [serial online]. J Natl Cancer Inst. 2015;107:djv048.
18. Ryerson AB, Eheman CR, Altekruse SF, et al. Annual report to the nation on the status of cancer, 1975-2012, featuring the increasing incidence of liver cancer. Cancer. 2016;122:1312-1337.
19. Jemal A, Ward EM, Johnson CJ, et al. Annual report to the nation on the status of cancer, 1975-2014, featuring survival. J Natl Cancer Inst. 2017;109:djx030.
20. North American Association of Central Cancer Registries (NAACCR). NAACCR Certification Criteria. North American Association of Central Cancer Registries Web site. Available at: https://www.naaccr.org/certification-criteria/. Accessed October 3, 2017.
21. World Health Organization. International Classification of Diseases for Oncology. 3rd ed. Geneva, Switzerland: World Health Organization Press; 2000.
22. Howlader N, Noone AM, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2014. Bethesda, MD: National Cancer Institute; 2016. Available at: https://seer.cancer.gov/csr/1975_2014/. Accessed October 3, 2017.
23. Clegg LX, Feuer EJ, Midthune DN, Fay MP, Hankey BF. Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst. 2002;94:1537-1545.
24. National Center for Health Statistics. Mortality Data, 2015. Atlanta, GA: National Vital Statistics System, National Center for Health Statistics, Centers for Disease Control and Prevention; 2017. Available at: https://www.cdc.gov/nchs/nvss/deaths.htm. Accessed November 21, 2017.
25. Espey DK, Jim MA, Richards TB, Begay C, Haverkamp D, Roberts D. Methods for improving the quality and completeness of mortality data for American Indians and Alaska Natives. Am J Public Health. 2014;104(suppl 3):286-294.
26. Espey DK, Wiggins CL, Jim MA, Miller BA, Johnson CJ, Becker TM. Methods for improving cancer surveillance data in American Indian and Alaska Native populations. Cancer. 2008;113(suppl 5):1120-1130.
27. Arias E, Heron M, Hakes JK. The validity of race and Hispanic-origin reporting on death certificates in the United States: an update. [DHHS Publication No. 2016-1372]. Vital Health Stat 2. 2016;172:1-21. Available at: https://www.cdc.gov/nchs/data/series/sr_02/sr02_172.pdf. Accessed December 10, 2017.
28. Altekruse SF, Cosgrove C, Cronin KA, Yu M. Comparing cancer registry abstracted and self-reported data on race and ethnicity. J Registry Manag. 2017;44:30-33.
29. Surveillance, Epidemiology, and End Results (SEER) Program. Population Estimates Used in NCI's SEER*Stat Software. Bethesda, MD: SEER Program, National Cancer Institute; 2015. http://seer.cancer.gov/popdata/methods.html. Accessed July 13, 2015.
30. National Vital Statistics System. Bridged-Race Population Estimates—Data Files and Documentation. Atlanta, GA: National Center for Health Statistics, Centers for Disease Control and Prevention; 2016. Available at: https://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.htm. Accessed December 22, 2016.
31. Ingram DD, Parker JD, Schenker N. United States Census 2000 population with bridged race categories. Vital Health Stat 2. 2003;135:1-55.
32. Greene FL, Page DL, Fleming ID, et al, eds. AJCC Cancer Staging Manual. 6th ed. Chicago, IL: American Joint Committee on Cancer; 2002.
33. Weir HK, Johnson CJ, Mariotto AB, et al. Evaluation of North American Association of Central Cancer Registries' (NAACCR) data for use in population-based cancer survival studies. J Natl Cancer Inst Monogr. 2014;2014:198-209.
34. Surveillance Research Program, National Cancer Institute. SEER*Stat Software (www.seer.cancer.gov/seerstat) version 8.3.4. Bethesda, MD: National Cancer Institute; 2017. Available at: https://seer.cancer.gov/seerstat. Accessed March 23, 2017.
35. Tiwari RC, Clegg LX, Zou Z. Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res. 2006;15:547-569.
36. Surveillance Research Program. Cancer Incidence Rates Adjusted for Reporting Delay. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences; 2017. Available at: https://surveillance.cancer.gov/delay. Accessed April 5, 2018.
37. Surveillance Research Program. Joinpoint Regression Program, version 4.2.0.2. Bethesda, MD: Surveillance Research Program, National Cancer Institute. Available at: https://surveillance.cancer.gov/joinpoint/ Accessed June 23, 2015.
38. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335-351.
39. Surveillance Research Program. Average Annual Percent Change (AAPC) and Confidence Interval. Bethesda, MD: National Cancer Institute; 2017. Available at: https://surveillance.cancer.gov/help/joinpoint/setting-parameters/method-and-parameters-tab/apc-aapc-tau-confidence-intervals. Accessed May 7, 2018.
40. Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK. Estimating average annual per cent change in trend analysis. Stat Med. 2009;28:3670-3682.
41. American Cancer Society. Cancer Facts & Figures 2017. Atlanta, GA: American Cancer Society; 2017. Available at: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2017/cancer-facts-and-figures-2017.pdf. Accessed May 7, 2018.
42. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295:2164-2167.
43. Vaccarella S, Franceschi S, Bray F, Wild CP, Plummer M, Dal Maso L. Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis. N Engl J Med. 2016;375:614-617.
44. Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends in thyroid cancer incidence and mortality in the United States, 1974-2013. JAMA. 2017;317:1338-1348.
45. Ward EM, Jemal A, Chen A. Increasing incidence of thyroid cancer: is diagnostic scrutiny the sole explanation? Future Oncol. 2010;6:185-188.
46. Jayson M, Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology. 1998;51:203-205.
47. Ravdin PM, Kronin KA, Howlader N, et al. The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med. 2007;356:1670-1674.
48. Jemal A, Ward E, Thun MJ. Recent trends in breast cancer incidence rates by age and tumor characteristics among US women [serial online]. Breast Cancer Res. 2007;9:R28.
49. Fedewa SA, de Moor JS, Ward EM, et al. Mammography use and physician recommendation after the 2009 US Preventive Services Task Force breast cancer screening recommendations. Am J Prev Med. 2016;50:e123-e131.
50. Jemal A, Saraiya M, Patel P, et al. Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006. J Am Acad Dermatol. 2011;65(5 suppl 1):S17-S25.e1-e3.
51. Dickman PW, Adami HO. Interpreting trends in cancer patient survival. J Intern Med. 2006;260:103-117.
52. National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. The Health Consequences of Smoking: 50 Years of Progress—A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention; 2014.
53. Jacobs EJ, Newton CC, Carter BD, et al. What proportion of cancer deaths in the contemporary United States is attributable to cigarette smoking? Ann Epidemiol. 2015;25:179-182.e171.
54. Lortet-Tieulent J, Goding Sauer A, Siegel RL, et al. State-level cancer mortality attributable to cigarette smoking in the United States. JAMA Intern Med. 2016;176:1792-1798.
55. Siegel RL, Jacobs EJ, Newton CC, et al. Deaths due to cigarette smoking for 12 smoking-related cancers in the United States. JAMA Intern Med. 2015;175:1574-1576.
56. Plevritis SK, Munoz D, Kurian AW, et al. Association of screening and treatment with breast cancer mortality by molecular subtype in US women, 2000-2012. JAMA. 2018;319:154-164.
57. Jemal A, Fedewa SA, Ma J, et al. Prostate cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations. JAMA. 2015;314:2054-2061.
58. Jemal A, Ma J, Siegel R, Fedewa S, Brawley O, Ward EM. Prostate cancer incidence rates 2 years after the US Preventive Services Task Force recommendations against screening. JAMA Oncol. 2016;2:1657-1660.
59. Rao SR, Breen N, Graubard BI. Trends in black-white disparities in breast and colorectal cancer screening rates in a changing screening environment: the Peters-Belson approach using United States National Health Interview Surveys 2000-2010. Med Care. 2016;54:133-139.
60. Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67:177-193.
61. Centers for Medicare and Medicaid Services (CMS), HHS. Medicare program; revisions to payment policies and 5-year review of and adjustments to the relative value units under the physician fee schedule for calendar year 2002: final rule with comment period. Fed Regist. 2001;66:55246-55503.
62. Islami F, Goding Sauer A, Miller KD, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. 2018;68:31-54.
63. Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29:4294-4301.
64. Sonawane K, Suk R, Chiao EY, et al. Oral human papillomavirus infection: differences in prevalence between sexes and concordance with genital human papillomavirus infection, NHANES 2011 to 2014. Ann Intern Med. 2017;167:714-724.
65. Liebler CA, Halpern-Manners A. A practical approach to using multiple-race response data: a bridging method for public-use microdata. Demography. 2008;45:143-155.